These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 6423614)
1. Ceftazidime and renal function. Alestig K; Trollfors B; Andersson R; Olaison L; Suurküla M; Norrby SR J Antimicrob Chemother; 1984 Feb; 13(2):177-81. PubMed ID: 6423614 [TBL] [Abstract][Full Text] [Related]
2. 68Ga-EDTA PET/CT imaging and plasma clearance for glomerular filtration rate quantification: comparison to conventional 51Cr-EDTA. Hofman M; Binns D; Johnston V; Siva S; Thompson M; Eu P; Collins M; Hicks RJ J Nucl Med; 2015 Mar; 56(3):405-9. PubMed ID: 25678493 [TBL] [Abstract][Full Text] [Related]
3. 51Cr-EDTA measurements of the glomerular filtration rate in patients with sickle cell anaemia and minor renal damage. Barros FB; Lima CS; Santos AO; Mazo-Ruiz MF; Lima MC; Etchebehere EC; Costa FF; Saad ST; Camargo EE; Ramos CD Nucl Med Commun; 2006 Dec; 27(12):959-62. PubMed ID: 17088681 [TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy. Walstad RA; Dahl K; Hellum KB; Thurmann-Nielsen E Eur J Clin Pharmacol; 1988; 35(3):273-9. PubMed ID: 3053209 [TBL] [Abstract][Full Text] [Related]
5. Effects on renal function of treatment with cefoxitin alone or in combination with furosemide. Trollfors B; Norrby R; Kristianson K; Nilsson NJ Scand J Infect Dis Suppl; 1978; (13):73-7. PubMed ID: 356182 [TBL] [Abstract][Full Text] [Related]
6. Mannitol clearance for the determination of glomerular filtration rate-a validation against clearance of Kiss K; Molnár M; Söndergaard S; Molnár G; Ricksten SE Clin Physiol Funct Imaging; 2018 Jan; 38(1):10-16. PubMed ID: 27256921 [TBL] [Abstract][Full Text] [Related]
7. Correlation of estimated and measured glomerular filtration rate in patients with interposed bowel in the urinary tract. Gurung PM; Greenwell TJ; Shah PJ; Ockrim JL Scand J Urol Nephrol; 2011 Sep; 45(4):290-5. PubMed ID: 21449703 [TBL] [Abstract][Full Text] [Related]
8. [Monitoring renal function in patients treated with cytostatics]. Hartlev LB; Rotbøl CB; Bluhme H; Palshof T; Rehling M Ugeskr Laeger; 2008 Nov; 170(45):3664-7. PubMed ID: 18986617 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ceftazidime in patients with renal insufficiency. Welage LS; Schultz RW; Schentag JJ Antimicrob Agents Chemother; 1984 Feb; 25(2):201-4. PubMed ID: 6370127 [TBL] [Abstract][Full Text] [Related]
10. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933 [TBL] [Abstract][Full Text] [Related]
11. Is endogenous creatinine clearance still a reliable index of glomerular filtration rate in diabetic patients? Friedman R; De Azevedo MJ; Gross JL Braz J Med Biol Res; 1988; 21(5):941-4. PubMed ID: 3150296 [TBL] [Abstract][Full Text] [Related]
12. Estimation of residual glomerular filtration rate in peritoneal dialysis patients using cystatin C: comparison with 51Cr-EDTA clearance. Carter JL; Lane CE; Fan SL; Lamb EJ Nephrol Dial Transplant; 2011 Nov; 26(11):3729-32. PubMed ID: 21441400 [TBL] [Abstract][Full Text] [Related]
13. Effect of prostaglandin synthesis inhibition on glomerular filtration rate in renal transplant recipients. Marín C; Herrera J; Manzanares J; Rodríguez-Iturbe B Clin Nephrol; 1992 Dec; 38(6):329-33. PubMed ID: 1468164 [TBL] [Abstract][Full Text] [Related]
14. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance. Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750 [TBL] [Abstract][Full Text] [Related]
15. Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes. Farker K; Merkel U; Schweer H; Haerting J; Madani SF; Eggers R; Müller UA; Seyberth HW; Hoffmann A Eur J Clin Pharmacol; 2002 May; 58(2):85-91. PubMed ID: 12012138 [TBL] [Abstract][Full Text] [Related]
16. Ceftazidime in the elderly: appropriateness of twice-daily dosing. Sirgo MA; Norris S DICP; 1991 Mar; 25(3):284-8. PubMed ID: 2028636 [TBL] [Abstract][Full Text] [Related]
17. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752 [TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C as an endogenous marker of renal function in the elderly. Hojs R; Bevc S; Antolinc B; Gorenjak M; Puklavec L Int J Clin Pharmacol Res; 2004; 24(2-3):49-54. PubMed ID: 15689051 [TBL] [Abstract][Full Text] [Related]
19. Effects of indomethacin and misoprostol on renal function in healthy volunteers. Wilkie ME; Davies GR; Marsh FP; Rampton DS Clin Nephrol; 1992 Dec; 38(6):334-7. PubMed ID: 1468165 [TBL] [Abstract][Full Text] [Related]
20. A Population Pharmacokinetic Model for Kuan IHS; Duffull SB; Putt TL; Schollum JBW; Walker RJ; Wright DFB Clin Pharmacokinet; 2017 Jun; 56(6):671-678. PubMed ID: 27943221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]